Showing results (281-290 of 298) with videos related to
Sort By:
Pageof 30
International Journal of Cancer|March 28, 1997
Colorectal cancer in Egyptian patients under 40 years of ageA S Soliman, M L Bondy, B Levin, et al.Elife|October 16, 2019
Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72Carl Laflamme, Paul M McKeever, Rahul Kumar, et al.American Journal of Human Genetics|November 22, 2016
Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5AChanshuai Han, Reem Alkhater, Tawfiq Froukh, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)Martine Girard, Roxanne Larivière, David A Parfitt, et al.Biorxiv : the Preprint Server for Biology|July 3, 2023
Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsRiham Ayoubi, Joel Ryan, Michael S Biddle, et al.The EMBO Journal|July 4, 2003
Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor traffickingMartina Metzler, Bo Li, Lu Gan, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 20, 2012
Diversity of ARSACS mutations in French-CanadiansI Thiffault, M J Dicaire, M Tetreault, et al.Biorxiv : the Preprint Server for Biology|January 12, 2022
Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2Xuan Yang, Rebekah J Dickmander, Armin Bayati, et al.ACS Chemical Biology|June 20, 2022
Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-CoronavirusesXuan Yang, Rebekah J Dickmander, Armin Bayati, et al.Public Health|May 23, 2024
The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statementC Cook, L Reid, A M Elsharkawy, et al.Pageof 30